Related Experiment Video
Updated: Aug 9, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
The unequal burden of time toxicity
Whitney V Johnson1, Anne H Blaes1, Christopher M Booth2
1Department of Internal Medicine, University of Minnesota, Minneapolis, MN, USA.
Cancer treatments cause significant time burdens, termed "time toxicity," which require consideration as adverse events. This study examines measures of time toxicity, focusing on healthcare access and resource allocation.
Area of Science:
- Oncology
- Health Services Research
- Patient-Reported Outcomes
Background:
- Cancer therapies often demand substantial patient time commitments.
- These time burdens, or 'time toxicity,' are increasingly recognized as critical adverse events.
- Understanding time toxicity is crucial for comprehensive cancer care.
Purpose of the Study:
- To discuss and define measures for quantifying 'time toxicity' in cancer care.
- To explore the impact of inequitable healthcare access on time toxicity.
- To analyze patterns and resource implications of time toxicity.
Main Methods:
- Literature review and conceptual analysis of time toxicity.
- Examination of healthcare access disparities.
- Discussion of time as a finite patient resource.
Main Results:
- Time toxicity is a significant, yet often overlooked, aspect of cancer treatment.
- Inequitable access exacerbates time toxicity for vulnerable patient populations.
- Varied patterns of time toxicity exist across different cancer types and treatments.
Conclusions:
- Time toxicity should be formally recognized and measured as a treatment-related adverse event.
- Addressing time toxicity requires strategies that mitigate healthcare access barriers.
- Optimizing cancer care necessitates a focus on preserving patient time as a valuable resource.
More Related Videos
08:24The Joint Effect of Social Comparison and Social Distance on Evaluation of Intertemporal Choice Outcomes in Event-related Potential Studies
Published on: August 25, 2023
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Related Concept Videos
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...